Epigenetic Remodeling Through GSK343-induced EZH2 Inhibition Alters SMYD2/SMYD3 Expression and Promotes Antitumor Effects.
- DOI
- 10.1016/j.clbc.2026.07.028
- Published
- 2026 Sep
- Container
- Clinical breast cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clbc.2026.07.028,
title = {Epigenetic Remodeling Through GSK343-induced EZH2 Inhibition Alters SMYD2/SMYD3 Expression and Promotes Antitumor Effects.},
author = {Silva TAD and Fernandes EV and Bocchi M and Neto FSL and de Oliveira FM},
year = {2026},
journal = {Clinical breast cancer},
doi = {10.1016/j.clbc.2026.07.028},
url = {https://doi.org/10.1016/j.clbc.2026.07.028}
}RIS
TY - JOUR TI - Epigenetic Remodeling Through GSK343-induced EZH2 Inhibition Alters SMYD2/SMYD3 Expression and Promotes Antitumor Effects. AU - Silva TAD AU - Fernandes EV AU - Bocchi M AU - Neto FSL AU - de Oliveira FM PY - 2026 JO - Clinical breast cancer DO - 10.1016/j.clbc.2026.07.028 UR - https://doi.org/10.1016/j.clbc.2026.07.028 ER -
APA
TAD, S., EV, F., M, B., FSL, N., & FM, D. O. (2026). Epigenetic Remodeling Through GSK343-induced EZH2 Inhibition Alters SMYD2/SMYD3 Expression and Promotes Antitumor Effects.. Clinical breast cancer. https://doi.org/10.1016/j.clbc.2026.07.028
Source records
- pubmed · retrieved 2026-09-27T15:54:29.447Z